FDA Leadership Change Boosts Drug Stocks

Kim Kahn notes the FDA naming Richard Pasdur to lead CDER and how analysts view the move positively for patients and industry.

Play episode from 01:41

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!